CIK 0001682852
- Large accelerated filer
Moderna, Inc.
Sign in to watch- Ticker
- MRNA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 813467528
- Phone
- +1 617-714-6500
- Business address
- 325 BINNEY STREET, CAMBRIDGE, MA, 02142
- Former names
- Moderna Therapeutics, Inc.
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- DEFA14A Proxy Proxy Materials
- ARS Other Annual Report to Security Holders
- PX14A6G Other Notice of Exempt Solicitation Submitted by Non-management
- PX14A6G Other Notice of Exempt Solicitation Submitted by Non-management
- DEFA14A Proxy Proxy Materials
- SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
- SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
- DEFA14A Proxy Proxy Materials
- S-3ASR Offering Registration Statement
- DEFA14A Proxy Proxy Materials
- S-8 Other Securities Offered to Employees in Benefit Plans
- FWP Offering Free Writing Prospectus
- FWP Offering Free Writing Prospectus
- S-3ASR Offering Registration Statement
- DEFA14A Proxy Proxy Materials
- S-8 Other Securities Offered to Employees in Benefit Plans
- S-8 Other Securities Offered to Employees in Benefit Plans
- CERT Other Certification
Page 10 of 11 · 210 filings